EFTR - eFFECTOR Therapeutics, Inc.
Previous close
0.1891
-11.761 -6,219.408%
Share volume: 0
Last Updated: Tue 02 Jul 2024 08:03:49 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$11.95
-11.76
-98.42%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-07 | 2023-03-08 | 2023-05-09 | 2023-08-08 | 2023-11-13 | |
| Cash flow financing | 2.733 M | -42.000 K | 111.000 K | -37.000 K | 212.000 K | 14.570 M | 342.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -6.497 M | -4.438 M | -8.184 M | -6.780 M | -7.637 M | -8.592 M | -7.755 M | |
| Net income | 3.069 M | -6.915 M | -9.559 M | -9.260 M | -10.014 M | -8.364 M | -8.303 M | |
| Depreciation | 5.000 K | 3.000 K | 18.000 K | 27.000 K | 28.000 K | 27.000 K | 26.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -28.274 M | 3.169 M | 3.623 M | 3.622 M | 9.027 M | -1.574 M | -1.915 M | |
| Net Borrowings | -28.423 M | -22.272 M | -15.436 M | -7.853 M | -657.000 K | -5.659 M | 1.117 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -57.000 K | -77.000 K | -45.000 K | -13.000 K | -13.000 K | -28.000 K | -2.000 K | |
| Cash Change | 45.706 M | 41.038 M | 32.956 M | 26.310 M | 19.007 M | 25.019 M | 17.779 M |